Brodimoprim

溴莫普林

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBrodimoprim

Drug Alias Name溴烯尿甙brodimoprimabrodimoprimum溴烯尿苷溴地普林 +[9]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDihydrofolate reductase inhibitors

TargetsDihydrofolate reductase

Therapy Area/IndicationsOtorhinolaryngologic DiseasesRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsOtorhinolaryngologic DiseasesRespiratory Tract Infections

Inactive IndicationsN/A

ATC CodeJ01EA02